Weeks 1-4: 1mg weekly (4mg total, small portion of first vial) Weeks 5-8: 2mg weekly (8mg total) Weeks 9-12: 4mg weekly (16mg total, finish first vial and start second) Weeks 13-16: 6mg weekly (24mg total, continue through second vial) Weeks 17-20: 8mg weekly (32mg total) Weeks 21-24: 8mg weekly maintenance (32mg total) Total peptide required: 116mg over 24 weeks Vials needed: 6 x 20mg vials with some remaining This protocol reaches 8mg maintenance by week 17 and holds there through week 24
This leads to reduced calorie intake and potentially significant weight loss over time
But since it may pose a risk to people with heart issues, she says its best suited for those who dont have coronary artery disease, hyperthyroidism, uncontrolled blood pressure or heart rhythm issues
Today, Walgreens Weight Management offers GLP-1 agonist medications such as semaglutide (Wegovy oral pills & injectable pens), tirzepatide (Zepbound injectable KwikPens & vials), orforglipron (Foundayo pills), and liraglutide (Saxenda )
Studies show a direct link between the concentration of the drug in the bloodstream and the frequency of nausea
That doesn't automatically mean the practice is unsafe or ineffective, but it does mean you're venturing beyond what has been formally studied and approved
